id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-N-5431-0001,FDA,FDA-2023-N-5431,"Hospira, Inc., et al.; Withdrawal of Approval of Eight Abbreviated New Drug Applications",Notice,Withdrawal,2023-12-19T05:00:00Z,2023,12,2023-12-19T05:00:00Z,,2023-12-19T16:19:50Z,2023-27853,0,0,0900006486346be7